Sara Nochur

870 total citations
13 papers, 679 citations indexed

About

Sara Nochur is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Sara Nochur has authored 13 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Sara Nochur's work include Respiratory viral infections research (6 papers), Transplantation: Methods and Outcomes (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). Sara Nochur is often cited by papers focused on Respiratory viral infections research (6 papers), Transplantation: Methods and Outcomes (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). Sara Nochur collaborates with scholars based in United States, Germany and Australia. Sara Nochur's co-authors include Jared Gollob, Akshay Vaishnaw, Jeffrey Cehelsky, John P. DeVincenzo, Tom Wilkinson, Edward E. Walsh, Rachel Meyers, Rob Lambkin‐Williams, Martin R. Zamora and Jens Gottlieb and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Sara Nochur

13 papers receiving 656 citations

Peers

Sara Nochur

EPIDE

PRM

SURGE

Yinghua Tang China

Satomi Hoshino United States

Carla D. Pretto United States

Sunee Techaarpornkul Thailand

Patrizia Di Marco Italy

Fiona Fernandes United States

Terrence O’Day United States

Yanli Qin China

Jie Deng China

Shaobo Jiang China

Yinghua Tang China

Sara Nochur

291 ×0.8

437 ×1.5

EPIDE

239 ×1.5

57 ×0.5

PRM

30 ×0.3

SURGE

Citations per year, relative to Sara Nochur Sara Nochur (= 1×) peers Yinghua Tang

Countries citing papers authored by Sara Nochur

Since Specialization

Citations

This map shows the geographic impact of Sara Nochur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Nochur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Nochur more than expected).

Fields of papers citing papers by Sara Nochur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Nochur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Nochur. The network helps show where Sara Nochur may publish in the future.

Co-authorship network of co-authors of Sara Nochur

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Nochur. A scholar is included among the top collaborators of Sara Nochur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Nochur. Sara Nochur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Adams, David, Teresa Coelho, Isabel Conceição, et al.. (2016). Phase 2 Open-Label Extension Study (OLE) of Patisiran, an Investigational RNAi Therapeutic for Familial Amyloid Polyneuropathy (FAP) (S38.003). Neurology. 86(16_supplement). 3 indexed citations

Adams, David, Teresa Coelho, Brian R. Bettencourt, et al.. (2015). Burden of Illness for Patients with familial amyloidotic Polyneuropathy (Fap) Begins Early and Increases with Disease Progression. Value in Health. 18(3). A287–A287. 1 indexed citations

Gottlieb, Jens, Martin R. Zamora, Tony N. Hodges, et al.. (2015). ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients. The Journal of Heart and Lung Transplantation. 35(2). 213–221. 120 indexed citations

Coelho, Teresa, Ole B. Suhr, Isabel Conceição, et al.. (2015). Phase 2 open-label extension study of patisiran, an investigational RNAi therapeutic for the treatment of familial amyloid polyneuropathy (S9.003). Neurology. 84(14_supplement). 5 indexed citations

Adams, David, Teresa Coelho, Ole B. Suhr, et al.. (2013). Interim results from phase ii trial of aln-ttr02, a novel RNAi therapeutic for the treatment of familial amyloidotic polyneuropathy. Journal of the Peripheral Nervous System. 18. 1–2. 2 indexed citations

Simon, Amy, Allan R. Glanville, Martin R. Zamora, et al.. (2012). Results of a phase 2b multi-center, randomized, double-blind, placebo-controlled study of an RNAi therapeutic, ALN-RSV01, in respiratory syncytial virus (RSV)-infected lung transplant patients. 40. 1858. 3 indexed citations

Fitzgerald, Kevin, Maria Frank-Kamenetsky, Timothy Mant, et al.. (2012). Abstract 67: Phase I Safety, Pharmacokinetic, and Pharmacodynamic Results for ALN-PCS, a Novel RNAi Therapeutic for the Treatment of Hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology. 32(suppl_1). 7 indexed citations

Zamora, Martin R., Marie Budev, Mark W. Rolfe, et al.. (2010). RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus. American Journal of Respiratory and Critical Care Medicine. 183(4). 531–538. 169 indexed citations

Zamora, Martin R., Marie Budev, Mark W. Rolfe, et al.. (2010). 41: Results of a Randomized Phase 2 Trial of ALN-RSV01, an RNAi Therapeutic, Lung Transplant (LTX) Patients Infected with Respiratory Syncytial Virus (RSV). The Journal of Heart and Lung Transplantation. 29(2). S20–S20. 4 indexed citations

10.

DeVincenzo, John P., Rob Lambkin‐Williams, Tom Wilkinson, et al.. (2010). A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proceedings of the National Academy of Sciences. 107(19). 8800–8805. 339 indexed citations

11.

DeVincenzo, John P., Rob Lambkin‐Williams, Jeff Cehelsky, et al.. (2008). Development of a Human Experimental Infection Model of Respiratory Syncytial Virus (RSV) and Evaluation of an RNA Interference (RNAi) Therapeutic for Safety and Anti-Viral Efficacy in Man. Journal of Allergy and Clinical Immunology. 121(2). S268–S268. 1 indexed citations

12.

Nochur, Sara, Gary R. Jacobson, Mary F. Roberts, & A.L. Demain. (1992). Mode of sugar phosphorylation inClostridium thermocellum. Applied Biochemistry and Biotechnology. 33(1). 33–41. 21 indexed citations

13.

Nochur, Sara. (1990). Mutation of Clostridium thermocellum in the presence of certain carbon sources. FEMS Microbiology Letters. 71(1-2). 199–204. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact